Security key
22663K107
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)
CUSIP: 22663K107
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 33,632,624
- Total 13F value
- $708,150,662
- Share change
- +759,575
- SEC-reported price per share
- $21.05
- Number of holders
- 91
- Value change
- +$17,177,215
- Number of buys
- 49
- Number of sells
- 25
- Shares outstanding
- 104,868,882
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
91
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 22663K107
Recent filing periods:
Ownership snapshot
Top reported holders of CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
91
Shares
33,632,624
Rows available
91
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
81
Q3 2021 holders
91
Holder diff
10
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend